Fazeli Zeinab, Pourhoseingholi Mohamad Amin, Vahedi Mohsen, Abadi Alireza, Fazeli Bavand-Pour Fatemeh Sadat, Baghestani Ahmad Reza
Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran J Cancer Prev. 2013 Summer;6(3):170-3.
Cancer is the third most common cause of death in Iran, the leukemia cancer is one of the most important causes of cancer mortality. Regarding cancer mortality, data would be important to monitor the program screening effects, earlier diagnosis, demographic data and other prognostic factors. The aim of this study was mortality rates evaluating, then leukemia cancer trends among the Iranian population within almost a period of a decade, i.e. from 1995 to 2004.
National death Statistic Reported by Ministry of Health and Medical Education (MOH&ME) from 1995 to 2004, stratified by age group, sex, and cause of death, have included in this study. Leukemia cancer has expressed as the annual mortality rates/100,000, in general, and/or per gender, and age group.
The general mortality rate of leukemia cancer has slightly increased within the mentioned study period, from 0.44 to 2.54, then leukemia cancer mortality has often seen in men more than women.
The mortality rate of leukemia has significantly increased throughout Iran. Associated risk factors with leukemia have headmost identified for their prevention and control. So, future studies to reveal leukemia risk factors among the Iranian population would be crucial in order to control its burden.
癌症是伊朗第三大常见死因，白血病是癌症死亡的最重要原因之一。关于癌症死亡率，数据对于监测筛查项目效果、早期诊断、人口数据及其他预后因素很重要。本研究的目的是评估死亡率，进而研究1995年至2004年近十年间伊朗人群中白血病的发病趋势。
本研究纳入了由卫生和医学教育部（MOH&ME）报告的1995年至2004年的国家死亡统计数据，这些数据按年龄组、性别和死因进行了分层。白血病的死亡率一般以每年每10万人计算，和/或按性别、年龄组计算。
在上述研究期间，白血病的总体死亡率略有上升，从0.44升至2.54，男性白血病死亡率通常高于女性。
伊朗全国白血病死亡率显著上升。已首先确定了与白血病相关的风险因素以进行预防和控制。因此，未来揭示伊朗人群中白血病风险因素的研究对于控制其负担至关重要。
